Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21
For those with chronic conditions, the peptide may provide long-term support by protecting tissues and strengthening overall resilience
Compound details
Dual-indication patients Many patients qualify for both indications
Because these compounds are naturally occurring peptides with restricted patentability, opportunities for intellectual property protection and industry-sponsored development are limitedposing substantial barriers to the resource-intensive clinical investigations required to confirm therapeutic efficacy and long-term safety
Privately owned and driven by patient outcomes, InfiniWell is fast-tracking clinical breakthroughs into accessible products for over 25k physicians and their patients
Oral BPC-157: indicated when the primary goal is GI-specific healing (gastric ulcers, IBD, leaky gut, gastroparesis)
US$ 27.69
US$ 25.97
US$ 22.82
US$ 20.19
US$ 20.30
US$ 20.94
US$ 23.53
US$ 24.28
US$ 24.61
US$ 26.83
US$ 26.15
US$ 22.41